HK Stock MarketDetailed Quotes
01858 CHUNLI MEDICAL
- 8.220
- +0.040+0.49%
Market Closed Dec 20 16:08 CST
3.15BMarket Cap17.95P/E (TTM)
8.410High8.180Low308.25KVolume8.180Open8.180Pre Close2.55MTurnover0.32%Turnover Ratio10.29P/E (Static)383.57MShares12.13252wk High1.02P/B782.05MFloat Cap6.08952wk Low0.49Dividend TTM95.14MShs Float62.017Historical High0.397Dividend LFY2.81%Amplitude0.279Historical Low8.281Avg Price250Lot Size5.94%Div YieldTTM4.83%Div Yield LFY
CHUNLI MEDICAL Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -37.33%78.96M | ---- | -9.72%277.82M | ---- | -19.75%125.99M | ---- | -4.54%307.72M | ---- | 0.92%156.98M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 39.56%-6.08M | ---- | -78.01%-12.01M | ---- | -183.00%-10.07M | ---- | ---6.75M | ---- | ---3.56M |
| Impairment and provisions: | ---- | -7.86%11.02M | ---- | -17.33%25.02M | ---- | -28.70%11.96M | ---- | 10.91%30.27M | ---- | 63.90%16.78M |
| -Other impairments and provisions | ---- | -34.07%5.79M | ---- | -74.34%4.32M | ---- | -38.59%8.79M | ---- | 0.25%16.82M | ---- | 49.07%14.31M |
| Revaluation surplus: | ---- | -6.57%-4.67M | ---- | -1.27%-9.61M | ---- | -10.60%-4.38M | ---- | ---9.49M | ---- | ---3.96M |
| Asset sale loss (gain): | ---- | ---39.21K | ---- | 84.57%-3.9K | ---- | ---- | ---- | -70.33%-25.31K | ---- | -208.84%-25.31K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---39.21K | ---- | 84.57%-3.9K | ---- | ---- | ---- | -70.33%-25.31K | ---- | -208.84%-25.31K |
| Depreciation and amortization: | ---- | 15.30%18.65M | ---- | 14.90%34.66M | ---- | 21.74%16.18M | ---- | 62.81%30.16M | ---- | 52.26%13.29M |
| -Amortization of intangible assets | ---- | 15.89%5.36M | ---- | 38.14%10.78M | ---- | 57.63%4.63M | ---- | 114.53%7.81M | ---- | 97.28%2.94M |
| -Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -41.67%128.33K | ---- | 0.00%110K |
| Financial expense | ---- | -97.99%-1.26M | ---- | 100.60%90.11K | ---- | -93.84%-634.25K | ---- | -107.87%-15.01M | ---- | 91.55%-327.2K |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 29.17%-91.14M | ---- | -70.22%-193.31M | ---- | -412.51%-128.68M | ---- | -7,093.76%-113.56M | ---- | -112.66%-25.11M |
| Accounts receivable (increase)decrease | ---- | -51.70%11.8M | ---- | 171.54%294.85M | ---- | 111.08%24.43M | ---- | -83.12%-412.17M | ---- | -159.03%-220.52M |
| Accounts payable increase (decrease) | ---- | -17.12%-89.39M | ---- | -58.85%94.75M | ---- | -337.45%-76.32M | ---- | 642.73%230.27M | ---- | 69.13%-17.45M |
| Special items of business | ---- | 20.60%3.09M | ---- | -33.83%-539.07K | ---- | 7.55%2.56M | ---- | 19.74%-402.79K | ---- | 35.42%2.38M |
| Adjustment items of business operations | -225.68%-17.28M | -73.71%-72.14M | -7.83%-129.61M | 1,137.02%512.25M | 118.00%13.75M | 50.49%-41.53M | -497.38%-120.2M | -74.95%41.41M | -231.72%-76.37M | -587.98%-83.89M |
| Net cash from operations | -225.68%-17.28M | -77.20%-69.06M | -7.83%-129.61M | 1,147.85%511.71M | 118.00%13.75M | 52.19%-38.97M | -497.38%-120.2M | -75.11%41.01M | -231.72%-76.37M | -530.17%-81.51M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -5.80%12.96M | -16.35%11.46M | -11.16%5.49M | 65.56%22.37M | 11.79%13.75M | 105.10%13.7M | --6.18M | --13.51M | --12.3M | --6.68M |
| Sale of fixed assets | --89.09K | --21K | --437.73K | -90.39%6.1K | ---- | ---- | ---- | 43.78%63.5K | 86.76%63.5K | 86.76%63.5K |
| Purchase of fixed assets | 6.88%-32.22M | -14.11%-21.84M | -1,215.97%-13.5M | -33.48%-33.24M | 39.64%-34.6M | 29.37%-19.14M | 95.17%-1.03M | 87.51%-24.9M | 68.74%-57.32M | 76.00%-27.1M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---6.99M | ---6.99M | ---3.69M | ---9.6M | ---- | ---- | ---- |
| Recovery of cash from investments | 2.93%1.57B | -7.49%1.41B | 8.67%831.3M | 66.57%2.35B | -0.83%1.53B | 65.67%1.52B | --765M | --1.41B | --1.54B | --920M |
| Cash on investment | 5.00%-1.5B | 16.40%-1.32B | 2.50%-740M | -10.86%-2.41B | 22.14%-1.58B | -11.99%-1.58B | -13.28%-759M | ---2.17B | ---2.03B | ---1.41B |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 52.11%13.72M | ---- | ---- |
| Net cash from investment operations | 162.34%50.83M | 224.56%79.64M | 5,297.49%83.73M | 89.31%-81.56M | 84.76%-81.53M | 87.47%-63.93M | 100.22%1.55M | -300.64%-762.61M | -203.02%-534.95M | -370.44%-510.36M |
| Net cash before financing | 149.49%33.55M | 110.28%10.58M | 61.33%-45.89M | 159.61%430.16M | 88.91%-67.79M | 82.61%-102.91M | 83.30%-118.65M | -2,723.04%-721.6M | -415.61%-611.32M | -561.04%-591.87M |
| Cash flow from financing activities | ||||||||||
| Dividends paid - financing | -15.59%-138.77M | ---- | ---- | -140.32%-120.06M | -139.92%-120.06M | ---- | ---- | ---49.96M | ---50.04M | ---36.94M |
| Other items of the financing business | -673.26%-5.59M | -318.43%-554.4K | ---- | 85.93%-1.28M | 91.78%-722.7K | 88.93%-132.5K | ---202.69K | -313.55%-9.08M | -421.72%-8.79M | 6.34%-1.2M |
| Net cash from financing operations | -19.52%-144.36M | -318.43%-554.4K | ---- | -105.53%-121.33M | -105.30%-120.78M | 99.65%-132.5K | ---202.69K | -105.50%-59.04M | -3,391.42%-58.83M | -2,884.11%-38.13M |
| Effect of rate | -99.75%1.68K | 90.45%1.28M | ---4.21K | -100.31%-4.21K | -67.29%673.56K | 86.11%673.56K | ---- | 177.70%1.34M | 411.30%2.06M | 176.98%361.91K |
| Net Cash | 41.24%-110.81M | 109.73%10.02M | 61.39%-45.89M | 139.56%308.82M | 71.86%-188.56M | 83.64%-103.04M | 83.27%-118.85M | -174.48%-780.64M | -457.31%-670.15M | -593.73%-630M |
| Begining period cash | 32.26%1.27B | 32.26%1.27B | 32.26%1.27B | -44.88%957.19M | -44.88%957.19M | -44.88%957.19M | -44.88%957.19M | 151.62%1.74B | 151.62%1.74B | 151.62%1.74B |
| Cash at the end | 50.16%1.16B | 49.42%1.28B | 45.54%1.22B | 32.26%1.27B | -28.00%769.3M | -22.77%854.83M | -18.28%838.34M | -44.88%957.19M | 87.70%1.07B | 84.83%1.11B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data